Background
Since May 2021 | Postdoctoral Fellow |
2016-2020 | PhD Student at the EPFL |
2015 | Postgraduate intern at Novartis |
2013-2014 | Undergraduate internship at Actelion Pharmaceuticals |
2011-2015 | BSci & MSci Chemistry with a Year in Industry at University of Nottingham (UK) |
My current research interest is focused on the development of a versatile diagnostic PET imaging platform with broad clinical utility. Specifically, I am aiming to generate a portfolio of diabody-based radiopharmaceuticals for various relevant targets in the context of cancer immunotherapy. This multidisciplinary project spanning from radiopharmaceutical development through protein and T cell engineering to in silico design is anticipated to generate an improved tool-set to allow for better clinical decision making.
Molinas M, Faizova R, Brown A, Galanzew J, Schacherl B, Bartova B, Meibom KL, Vitova T, Mazzanti M, Bernier-Latmani R
Environ Sci Technol. 2021 Apr 20;55(8):4753-4761
Faizova R, Fadaei-Tirani F, Chauvin AS, Mazzanti M
Angew Chem Int Ed Engl. 2021 Apr 6;60(15):8227-8235
Faizova R, Scopelliti R, Chauvin AS, Mazzanti M
J Am Chem Soc. 2018 Oct 24;140(42):13554-13557
Faizova R, White S, Scopelliti R, Mazzanti M
Chem Sci. 2018 Oct 14;9(38):7520-7527